127 related articles for article (PubMed ID: 9006732)
1. Treatment of radioiodine-negative bone metastasis from papillary thyroid carcinoma with percutaneous ethanol injection therapy.
Nakada K; Kasai K; Watanabe Y; Katoh C; Kanegae K; Tsukamoto E; Itoh K; Tamaki N
Ann Nucl Med; 1996 Nov; 10(4):441-4. PubMed ID: 9006732
[TBL] [Abstract][Full Text] [Related]
2. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma.
Lim CY; Yun JS; Lee J; Nam KH; Chung WY; Park CS
Thyroid; 2007 Apr; 17(4):347-50. PubMed ID: 17465865
[TBL] [Abstract][Full Text] [Related]
4. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
[TBL] [Abstract][Full Text] [Related]
5. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky AZ; Freeman LM
J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
[No Abstract] [Full Text] [Related]
6. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
7. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
Dadparvar S; Chevres A; Tulchinsky M; Krishna-Badrinath L; Khan AS; Slizofski WJ
Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
10. Functioning metastasis of papillary thyroid carcinoma originating as a double star effect on the post-therapeutic radioiodine whole body scan.
Anastasios G; Foteini C; Dimitrios T; Philippos K
Intern Med; 2008; 47(12):1155-6. PubMed ID: 18552478
[No Abstract] [Full Text] [Related]
11. [Tumor redifferentiation in papillary thyroid carcinoma alter retinoic acid administration].
Camacho Martí V; Estorch Cabrera M; Mena González E; Fuertes Manuel J; Hernández Fructuoso MA; Flotats Giralt A; Carrió Gasset I
Rev Esp Med Nucl; 2004; 23(3):193-6. PubMed ID: 15153363
[TBL] [Abstract][Full Text] [Related]
12. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma.
Van Tol KM; Hew JM; Jager PL; Vermey A; Dullaart RP; Links TP
Clin Endocrinol (Oxf); 2000 May; 52(5):653-9. PubMed ID: 10792347
[TBL] [Abstract][Full Text] [Related]
13. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
[TBL] [Abstract][Full Text] [Related]
14. Histological study of papillary thyroid carcinoma treated with percutaneous ethanol injection therapy.
Akasu H; Shimizu K; Kitagawa W; Naito Z; Kawanami O; Tanaka S
Pathol Int; 2002; 52(5-6):406-9. PubMed ID: 12100524
[TBL] [Abstract][Full Text] [Related]
15. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with emphasize on the thallium scintigraphy in these subgroups.
Zakani A; Saghari M; Eftekhari M; Fard-Esfahani A; Fallahi B; Esmaili J; Assadi M
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1215-21. PubMed ID: 22165686
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy for differentiated thyroid carcinoma.
Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
[TBL] [Abstract][Full Text] [Related]
19. [Docetaxel administration for radioiodine-resistant patients with metastatic papillary thyroid carcinoma].
Ikeda M; Tanaka K; Sonoo H; Miyake A; Yamamoto Y; Shiiki S; Nakashima K; Kurebayashi J
Gan To Kagaku Ryoho; 2007 Jun; 34(6):933-6. PubMed ID: 17565260
[TBL] [Abstract][Full Text] [Related]
20. A Clear Cell Variant of Papillary Thyroid Microcarcinoma With Lung, Bone, and Soft Tissue Metastases.
Yazici B; Ertan Y; Oral A; Akgün A
Clin Nucl Med; 2015 Nov; 40(11):885-7. PubMed ID: 26018685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
